Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: A literature review

Journal of Cardiovascular Nursing

Volumn 23, Issue 6, 2008, Pages 489-496

  Regan, Karen L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Acute coronary syndrome; Depression; Myocardial infarction; Selective serotonin reuptake inhibitors

Indexed keywords

CYTOCHROME P450; SEROTONIN UPTAKE INHIBITOR;

ACUTE CORONARY SYNDROME; CHEMICALLY INDUCED DISORDER; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFECT; HEART ARRHYTHMIA; HUMAN; INCIDENCE; METHODOLOGY; MORBIDITY; NAUSEA; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SAFETY; SEXUAL DYSFUNCTION; SWEATING; TREATMENT OUTCOME; WAKEFULNESS;

ACUTE CORONARY SYNDROME; ARRHYTHMIAS, CARDIAC; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER; DIARRHEA; DIZZINESS; HUMANS; INCIDENCE; MORBIDITY; NAUSEA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK FACTORS; SAFETY; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SWEATING; TREATMENT OUTCOME; WAKEFULNESS;

EID: 58149330638     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/01.JCN.0000338929.89210.af     Document Type: Article

References (19)

1. Depression page. The World Health Organization Web site. http://www.who.int/mental-health/management/ depression/definition/en/. Accessed June 1, 2007.
2. Murray CJ, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 1997;349:1498-1504.
3. Jiang W, Krishnan RR, O'Connor CM. Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs. 2002;16:111-127.
4. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 2001;88:337-341.
5. Swenson JR, O'Connor CM, Barton D. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol. 2003;92:1271-1276.
6. Glassman AH, Roose SP, Bigger Jr JT. The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA. 1993;306:683-687.
7. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108:2-8.
8. Parissis JT, Fountoulaki K, Filippatos G, Adamopoulos S, Paraskevaidis I, Kremastinos D. Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications. Int J Cardiol. 2007;116:153-160.
9. Peterson AM, Natale F. In Depressive Disorder: Arcangelo VP, Peterson AM, eds. Pharmacotherapeutics for Advanced Practice: A Practical Approach. 2nd ed. Philadelphia, PA: Lipincott Williams & Wilkins; 2006:609-621.
10. Maurer-Spurej E. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell Mol Life Sci. 2005;62:159-170.
11. Lesperance F, Frasure-Smith N, Laliberte M, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297:367-379.
12. Strik JJ, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med. 2000;62:783-789.
13. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701-709.
14. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA. 2003;289: 3106-3116.
15. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62:792-798.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
17. Beck AT, Ward CH, Mendelson M, Mock J, Eubaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:53-63.
18. Institute for Clinical Systems Improvement. Guideline.gov website. Major depression in adults in primary care. http:// www.guideline.gov/search/ searchresults.aspx?Type= 3&txtSearch= depression+and+myocardial+infarction& num=20. Accessed June 5, 2007.
19. Jiang W, Krishnan RR. Should selective serotonin reup-take inhibitors be prescribed to all patients with ischemic heart disease? Curr Psychiatry Rep. 2004;6:202-209.